https://www.torray.com https://www.torray.com/about/our-team https://www.torray.com/strategies/large-growth-strategy https://www.torray.com/strategies/small-mid-cap-growth-strategy https://www.torray.com/strategies/equity-income-strategy https://www.torray.com/legal-disclosures https://www.torray.com/investment-vehicles/managed-accounts https://www.torray.com/about/investment-approach https://www.torray.com/about/our-founder https://www.torray.com/contact https://www.torray.com/resources/investment-resources https://www.torray.com/resources/literature https://www.torray.com/insights/jeff-lent-portfolio-manager-of-the-torray-equity-income-strategy https://www.torray.com/insights/talking-tariffs-with-director-of-research-james-bailey-cfa https://www.torray.com/documents/bob-torrays-lasting-impact https://www.torray.com/documents/eyes-of-the-world https://www.torray.com/documents/eyes-of-the-world---december-2025 https://www.torray.com/documents/eyes-of-the-world---march-2026 https://www.torray.com/documents/eyes-of-the-world---november-2025 https://www.torray.com/documents/form-adv-part-2 https://www.torray.com/documents/form-crs-client-relationship-summary https://www.torray.com/documents/perspectives-on-20-years-of-income-investing https://www.torray.com/documents/privacy-notice https://www.torray.com/documents/talking-tariffs https://www.torray.com/documents/torray-strategies---first-quarter-2026-commentary-and-review https://www.torray.com/documents/under-appreciated-value-in-biotech